Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
PEGASUS trial
Description:
A clinical trial of ticagrelor for preventing cardiovascular events in patients with a history of myocardial infarction.
Primary topic:
Complement system in diseases (39%)
Related topics:
Complement system in diseases (39%),
Antiplatelet Therapy and Cardiovascular Diseases (32%)
OpenAlex ID:
keywords/pegasus-trial
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial
2022
·
Régis Peffault de Latour
, Jeff Szer
, et al.
·
The Lancet Haematology
·
87
PDF
LBA28 The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients
2023
·
S. Lonardi
, F. Pietrantonio
, et al.
·
Annals of Oncology
·
60
PDF
Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuria
2022
·
Raymond S.M. Wong
·
Therapeutic Advances in Hematology
·
42
The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients.
2020
·
Sara Lonardi
, Clara Montagut
, et al.
·
Journal of Clinical Oncology
·
40
Pressure garment to prevent abnormal scarring after burn injury in adults and children: the PEGASUS feasibility RCT and mixed-methods study
2018
·
Naiem Moiemen
, Jonathan Mathers
, et al.
·
Health Technology Assessment
·
39
PDF
Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study
2024
·
Dedee F. Murrell
, Frédéric Caux
, et al.
·
Journal of Investigative Dermatology
·
35
PDF
Fondaparinux: an update on new study results
2005
·
R. M. Bauersachs
·
European Journal of Clinical Investigation
·
35
Hemolysis events in the phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria
2024
·
Régis Peffault de Latour
, Morag Griffin
, et al.
·
Blood Advances
·
22
PDF
The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis
2009
·
W Rogowski
, J Burch
, et al.
·
Health Technology Assessment
·
20
PDF
723O Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients: Final results of the PEGASUS trial
2025
·
S. Marsoni
, M. Prisciandaro
, et al.
·
Annals of Oncology
·
16
Ticagrelor shift from PLATO to PEGASUS: Vanished mortality benefit, excess cancer deaths, massive discontinuations, and overshooting target events
2015
·
Victor L. Serebruany
·
International Journal of Cardiology
·
16
Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria
2022
·
Young-A Heo
·
Drugs
·
15
Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease
2024
·
Steven E. Arnold
, Suzanne Hendrix
, et al.
·
Alzheimer s & Dementia Translational Research & Clinical Interventions
·
13
PDF
Do randomized clinical trial selection criteria reflect levels of risk as observed in a general population of acute myocardial infarction survivors? The PEGASUS trial in the light of the FAST-MI 2005 registry
2016
·
Etienne Puymirat
, François Schiele
, et al.
·
International Journal of Cardiology
·
13
Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab
2020
·
Alexander Röth
, Britta Hoechsmann
, et al.
·
Blood
·
11
Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuria
2022
·
Bo Xu
·
Clinical and Experimental Medicine
·
10
Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?
2015
·
Victor L. Serebruany
, Ales Tomek
, et al.
·
Expert Review of Cardiovascular Therapy
·
10
Pegcetacoplan: the first and only C3-targeted therapy for the treatment of adults with paroxysmal nocturnal hemoglobinuria
2024
·
Tze Wei Chan
, Hein Than
, et al.
·
Expert Review of Hematology
·
9
Personalized mechanical ventilation guided by lung ultrasound in patients with ARDS: a pilot phase of a randomized clinical trial
2025
·
Jante S. Sinnige
, Marry R. Smit
, et al.
·
Intensive Care Medicine Experimental
·
8
PDF
Fatigue and health‐related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan PEGASUS trial data
2023
·
Jens Panse
, Koo Wilson
, et al.
·
European Journal Of Haematology
·
7
Mapping the EORTC QLQ-C30 onto the EQ-5D-5L index for patients with paroxysmal nocturnal hemoglobinuria in France
2023
·
Piotr Wojciechowski
, Marlena Wdowiak
, et al.
·
Journal of Comparative Effectiveness Research
·
7
Eligibility for extended antithrombotic therapy for secondary prevention of acute coronary syndrome
2020
·
Daniel Faria
, Miguel Santos
, et al.
·
Revista Portuguesa de Cardiologia
·
7
Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment
2023
·
Jesse Fishman
, Seri Anderson
, et al.
·
Hematology Reports
·
6
PDF
Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Pegcetacoplan Show Improvements in D-dimer Normalization and Decrease in Incidence of Thrombosis
2022
·
I. Weitz
, M. Al-Adhami
, et al.
·
HemaSphere
·
6
Duration of antiplatelet therapy after DES implantation: can we trust non-inferiority open-label trials?
2017
·
Philippe Gabriel Steg
, Tabassome Simon
·
European Heart Journal
·
6
Show more works
View as search
Works count:
138
Citation count:
645
Year
Topic
Type